Internal Medicine

At the annual HFSA meeting, investigators explain how obstructed sleep apnea and central sleep apnea drive cardiovascular disease.

Lab tests confirm low levels of NDMA in the popular heart burn medication, sparking a probe in the US and Europe.

A pair of new mesh products will optimize hernia surgery, while reinforcing soft tissue with twice the strength.

The FDA-approved drug targets IBS-C patients by increasing bowel movements, while lowering abdominal pain.

Through clinical trials, investigators find that SGLT2 inhibitors are not only safe, but have several cardiovascular benefits.

By allocating 1% of their day to exercise, patients can turn an unhealthy lifestyle into a healthy lifestyle.

Approximately 700,000 adults in the US as of 2016 are suffering from end-stage kidney disease, with transplantation viewed as the preferred treatment.

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

In a retrospective study using the data of 20,741 patients, investigators discover the primary cause of emergency department visits for geriatric patients is head trauma.

Investigators submit recommendations for physicians for Parkinson disease reflecting recent advancements, including a new section on palliative care.

Investigators find that sofosbuvir is less effective on some HCV infections because of certain amino acid substitutions.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

In a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.

Using a variety of tests to measure cognitive changes, investigators find that gender and education level does not impact cognitive decline as much as health and lifestyle factors.

In a 53-patient observational study, investigators discover they can safely transplant a HCV-infected kidney into a HCV-negative recipients.

Investigators find that opening all blockages with stents is more beneficial after a heart attack than targeting just the clogged artery causing the event.

An updated list of guidelines recommends using catheter ablation to treat supraventricular tachycardia.

From surgery to pediatrics to neurology, major healthcare innovations have been borne out of sports medicine headlines.

In a new clinical trial, investigators found a FAAH inhibitor improves the recall of fear extinction memories while reducing the impact of stress in PTSD patients.

The FDA warns of liver failure in rare cases from taking Mavyret, Zepatier, and Vosevi to treat hepatitis C.

Investigators find a gluten-free diet does not cause abdominal pain, reflux, indigestion, diarrhea, and constipation in non-gluten sensitive patients.

In a multi-country study, investigators find that the US could reduce the number of deaths for patients waiting for kidney transplants if they accept older kidneys.

A new FDA approval allows istradefylline to be taken as an add-on with other medication to reduce the time medication does not work in Parkinson disease patients.

A primary investigator-led discussion will tap into how invasive procedures have become more embraced in US cardiology.